Make Sure Patients Go Home on Only One ACEI or ARB

A shift in thinking about the CV benefits of ARBs will lead to more use of ARBs instead of ACE inhibitors.

We're used to using ACEIs...since they have more CV outcomes data and SEEMED to have a bigger impact on CV events than ARBs.

And low-cost generic ACEIs have been available for years.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals